ClinicalTrials.gg
CompletedNCT03577561Updated Jul 9, 2019

Proficiency Based Training to Investigate Blood Sampling Errors Including WBIT

An interventional study of Proficiency Based Progression Training in Phlebotomy in Blood Transfusion Complication, Wrong Blood in Tube and Pre Analytical Blood Sample Errors, sponsored by Patrick Henn. Completed at 1 site in Ireland. Per ClinicalTrials.gov, last updated 2019-07-09.

Sponsored by Patrick Henn · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
137
Allocation
Non-randomized
Sex
All
01

Study summary

The objective of this study is to determine the effectiveness of a Proficiency Based Progression training programme, together with evidence based individual feedback for any residual errors, which has been specifically developed for healthcare professionals performing phlebotomy at Cork University Hospital at reducing blood sampling errors including Wrong Blood in Tube (WBIT). This will allow us to internationally address the universal problem of sample mislabeling and WBIT. A pilot project which consisted of PBP delivered to 46 interns commencing work in July 2017 has shown a 47% reduction in haematology errors and a 67% reduction in WBITs in the haematology department. However, the sample size was small to result in a statistically significant reduction in WBITs and the investigators are concerned that the results were undermined by the fact that SHOs were not using the method outlined by the metric and may have influenced the standard practice of interns. This study by training interns and SHOs will be better able to determine the influence of the training programme in reducing error rates.

Read the detailed description

Objective To determine the effectiveness of a Proficiency Based Progression Training programme, together with evidence based individual feedback for any residual errors, which has been specifically developed for healthcare professionals performing phlebotomy at Cork University Hospital at reducing blood sampling errors including Wrong Blood in Tube (WBIT) .The investigators will use the research data generated to recommend an evidence based training and competency assessment approach to health care providers in Ireland,. This will allow us to internationally address the universal problem of sample mislabeling and WBIT.

METHODS Subjects All SHO (128) and intern (46) trainees working at participating sites during an 18-month timeframe will be asked to participate. For interns the investigators will expect their participation in the two weeks before they commence work in June/July 2018/9. For SHO's the investigators will ensure training is integrated as part of their normal work routine and hospital practices. Participation will be expected and the investigators have secured the backing of the hospital executive management group, clinical directors and university teachers for implementation of this study.

Proficiency based progression training The phlebotomy metric which was developed at CUH in 2017 is the provides the key tool in the development of the PBP training programme. All interns and SHOs in institutions participating in the study will receive PBP training. All trainees will be required to engage with an online didactic education package and a simulation skill training module. Both of these education and training platforms will be derived from the procedure characterisation and benchmarked on experienced practitioner's performance. Trainees will be required to engage with the education and training platforms in a process of deliberate practice learning until they demonstrate the requisite performance benchmark. Only at that point will they be allowed to take samples in a clinical setting. Proficiency demonstration will be mandatory before progressing to ward proctored skill supervision on real patients. In addition, the doctors in training will receive ongoing and proximate feedback on their sampling mislabeling (including wrong blood in tube) performance as soon as it is discovered. Furthermore, they would be responsible for taking the new sample and explain to the patient the accurate reason why the blood sample had to be re-taken, as per open disclosure policy in the HSE.

Comparison Groups The control groups will be derived from extensive baseline data from CUH hospitals from trainees

Control group A: 1 -year historical data (2016/2017) The blood sampling error rate in the interns receiving PBP training in 2018 will be compared to historical data on doctors who would have received whatever training they would normally undergo as a part of their existing training program. It will not differ from what they would normally receive at that institution.

Control group B (2017/2018) In a pilot project in July 2017, 46 interns received the phlebotomy PBP training at CUH. The error rates in the interns in 2017 will be compared to the newly trained interns in 2018 to determine the effectiveness of the training over time.

Data collection at Cork University Hospital The Medically qualified clinical researcher Dr Noirin O'Herlihy, will set up and co-ordinate training for the two medical groups. She will inform the Interns and SHO in formal and informal sessions. She will be present at session to ensure accurate simulation of real life ward environments. She will obtain written informed consent from the medics in simulation and collect baseline demographic data on all doctors in training participating in the study.

Once competency has been demonstrated in simulation, she will be responsible for setting up real life clinical, monitored competency assessment in the real ward setting. Data collection will take place using an agreed standard operating procedure which is closely adhered to by all data collection sites.

02

Conditions studied

  • Blood Transfusion Complication
  • Wrong Blood in Tube
  • Pre Analytical Blood Sample Errors

Browse trials for

03

In context

Transfusion Reaction

56 studies on the registry are indexed under Transfusion Reaction; 12 are open to participants now.

This study's enrollment of 137 is above the median of 71 across 23 interventional studies indexed under Transfusion Reaction.

Browse Transfusion Reaction studies →

Lead sponsor

Patrick Henn is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

All blood samples performed at Cork Unversity Hospital and Kerry General Hospital by Doctors in Training

Exclusion criteria

Exclusion Criteria:

If the doctor is not using his own log in to request blood samples on the clinical manager software If the doctor does not attend the training session

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
137 participants (actual)

Study arms

  • No intervention
    Control group A

    Control group A: 1 -year historical data (2016/2017) The blood sampling error rate in the interns receiving proficiency based progression training in 2018 will be compared to historical data on doctors who would have received whatever training they would normally undergo as a part of their existing training program. It will not differ from what they would normally receive at that institution.

  • Active comparator
    Control Group B

    Control group B (2017/2018) In a pilot project in July 2017, 46 interns received the phlebotomy proficiency based progression training at CUH. The error rates in the interns in 2017 will be compared to the newly trained interns in 2018 to determine the effectiveness of the training over time. The intervention is the proficiency based progression training programme in phlebotomy.

    Other: Proficiency Based Progression Training in Phlebotomy

  • Active comparator
    Interventional Group

    The blood sampling error rate of doctors in training provided with the intervention i.e. improved proficiency based progression training programme will be analysed from July 10th 2018 until the study ends. The proficiency based progression training will consist of an online eLearning module to teach the doctors the correct process to take blood in the hospital. The doctors will then have to attend a face to face training day on a simulation ward where they will be asked to take blood according to a metric of 77 steps with less than 13 errors and no critical errors. Finally, the doctors will be observed taking blood on the ward and again must take it to a proficient standard.

    Other: Proficiency Based Progression Training in Phlebotomy

Interventions

  • OtherProficiency Based Progression Training in Phlebotomy

    Trainees will receive an online didactic education package and a simulation skill training module. Both of these education and training platforms will be derived from the procedure characterisation and benchmarked on experienced practitioner's performance. Trainees will be required to engage with the education and training platforms in a process of deliberate practice learning until they demonstrate the requisite performance benchmark. Proficiency demonstration will be mandatory before progressing to ward proctored skill supervision on real patients. In addition, the doctors in training will receive ongoing and proximate feedback on their sampling mislabeling.

    Also known as: Medical Education, Simulation Training

06

What researchers measure

Primary outcomes

  1. Total Number of Rejected Samples due to pre-analytical errors

    The total number of blood samples that were not tested due to pre analytical errors by the doctors in training as a percentage of the total number of samples taken by the doctors

    Time frame: 6 months

Secondary outcomes

  1. Over and Underfilling of the specimen bottle

    Any sample not tested due to over or under filling of the bottle as a percentage of the total number of samples performed

    Time frame: 6 months

  2. Clotted Samples

    The number of samples not tested due to clotting of the sampleas a percentage of the total number of samples performed

    Time frame: 6 months

  3. Haemolysed Samples

    The number of blood samples not tested as the blood sample was haemolysedas a percentage of the total number of samples performed

    Time frame: 6 months

  4. No Specimen Received

    The number of blood requests received without a specimen bottleas a percentage of the total number of samples performed

    Time frame: 6 months

  5. Incorrect Bottle

    The number of blood requests received where the blood was taken in the incorrect specimen bottle as a percentage of the total number of samples performed

    Time frame: 6 months

  6. Other Causes for Rejected Samples

    Any other cause for the blood request not being processed as a percentage of the total number of samples performed

    Time frame: 6 months

  7. Wrong Blood in Tube

    The number of specimens where the blood sample in the tube is not that of the patient label on the specimen bottle as a percentage of the total number of samples performed

    Time frame: 6 months

07

Study locations

1 site
  • Cork University Hospital
    Cork, Munster T12 DC4A, Ireland
08

References and documents

Individual participant data

Plan to share: Yes — The study data will be made available once the study is completed by contacting the principal investigator

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: 18 months

Access criteria: At completion of the study

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2018 to primary completion in Dec 2018, 5 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 30, 2018
First posted
Jul 5, 2018
StartActual
Jul 4, 2018
Primary completionActual
Dec 4, 2018
CompletionActual
Jun 30, 2019
Last update
Jul 9, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 9, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03577561
Lead sponsor
Patrick Henn
Collaborators
Cork University Hospital
Responsible party
Patrick Henn (Investigator, University College Cork) — Sponsor-investigator
First posted
Jul 5, 2018
Start date
Jul 4, 2018
Primary completion
Dec 4, 2018
Completion
Jun 30, 2019
Last update
Jul 9, 2019

Study contacts

Anthony Gallagher, PhD
study director · University College Cork
Mary R Cahill, MD
principal investigator · University College Cork

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion